Background: Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic premalignant plasma cell disorder. Prevalence and clinical outcomes of MGUS in kidney transplant (KT) recipients have been previously reported in few studies with conflicting results. Methods: We conducted a retrospective study in a population of 548 KT recipients transplanted between 1998 and 2015. Results: Thirty-nine (8.1%) subjects developed MGUS after KT. At diagnosis of MGUS, the average age was 52 ± 9.2 years, and 23% of the patients were younger than 50 years. Occurrence of MGUS was not influenced by age and sex. After a mean follow-up of 7.8 years, only 1 (2.5%) patient progressed to multiple myeloma. We found no differences in the incidence of solid and hematological malignancies, serious infections, graft failure, and mortality between KT patients with MGUS and a matched cohort of KT recipients without MGUS. The MGUS group had a significantly higher prevalence of monoclonal B cell lymphocytosis, premalignant condition poorly described in KT recipients. Prior history of glomerulonephritis or interstitial nephritis, as cause of renal failure, represented the only predictive factor for MGUS development. Conclusions: MGUS is a premalignant disorder frequently encountered in KT recipients. We found no differences in clinical outcomes between MGUS patients and KT controls.
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience / Alfano, Gaetano; Fontana, Francesco; Colaci, Elisabetta; Messerotti, Andrea; Bettelli, Francesca; Potenza, Leonardo; Luppi, Mario; Cappelli, Gianni. - In: TRANSPLANTATION. - ISSN 0041-1337. - 101:11(2017), pp. e337-e342. [10.1097/TP.0000000000001884]
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience
Alfano, Gaetano;Fontana, Francesco;Colaci, Elisabetta;Messerotti, Andrea;Bettelli, Francesca;Potenza, Leonardo;Luppi, Mario;Cappelli, Gianni
2017
Abstract
Background: Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic premalignant plasma cell disorder. Prevalence and clinical outcomes of MGUS in kidney transplant (KT) recipients have been previously reported in few studies with conflicting results. Methods: We conducted a retrospective study in a population of 548 KT recipients transplanted between 1998 and 2015. Results: Thirty-nine (8.1%) subjects developed MGUS after KT. At diagnosis of MGUS, the average age was 52 ± 9.2 years, and 23% of the patients were younger than 50 years. Occurrence of MGUS was not influenced by age and sex. After a mean follow-up of 7.8 years, only 1 (2.5%) patient progressed to multiple myeloma. We found no differences in the incidence of solid and hematological malignancies, serious infections, graft failure, and mortality between KT patients with MGUS and a matched cohort of KT recipients without MGUS. The MGUS group had a significantly higher prevalence of monoclonal B cell lymphocytosis, premalignant condition poorly described in KT recipients. Prior history of glomerulonephritis or interstitial nephritis, as cause of renal failure, represented the only predictive factor for MGUS development. Conclusions: MGUS is a premalignant disorder frequently encountered in KT recipients. We found no differences in clinical outcomes between MGUS patients and KT controls.File | Dimensione | Formato | |
---|---|---|---|
Transplantation Alfano 2017.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
1.71 MB
Formato
Adobe PDF
|
1.71 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
VOR_Monoclonal_Gammopathy_of_Undetermined_Significance.pdf
Accesso riservato
Tipologia:
Versione pubblicata dall'editore
Dimensione
237.71 kB
Formato
Adobe PDF
|
237.71 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
TP.0000000000001884.pdf
Open access
Tipologia:
Versione dell'autore revisionata e accettata per la pubblicazione
Dimensione
1.71 MB
Formato
Adobe PDF
|
1.71 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris